FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 1705975 · Received May 28, 2010

Report

Report Number
1030489-2010-00744
Event Type
Injury
Date Received
May 28, 2010
Date of Event
January 1, 2008
Report Date
April 28, 2010
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC.
Product Code
NEK
PMA / PMN Number
P050053
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B) (4). LITERATURE ARTICLE CITATION: CARTER ET AL. OFF-LABEL USE OF RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2) FOR RECONSTRUCTION OF MANDIBULAR BONE DEFECTS IN HUMANS. JOURNAL OF ORAL MAXILLOFACIAL SURGERY 2008; 66: 1417-1425. A REVIEW OF THE CERTIFICATES OF ANALYSIS AND PACKING LIST FOR THE INFUSE BONE GRAFT WAS NOT POSSIBLE WITHOUT ADD'L DEVICE INFO. NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MFR FOR EVAL. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PT PRESENTED FOR EMERGENCY TREATMENT FOR A DISPLACED RIGHT MANDIBULAR ANGLE FRACTURE. THE DEFECT WAS RECONSTRUCTED USING RHBMP-2/ACS. PT HAD SIGNIFICANTLY MORE SWELLING THAN IS USUALLY OBSERVED WITH AN AUTOGENOUS FREE BONE GRAFT. A PANORAMIC RADIOGRAPH AT 2 MONTHS POSTOPERATIVELY SHOWS INDUCTION OF BONE GROWTH WITHIN THE DEFECT. EIGHT MONTHS POST OP THE PT WAS STILL EXPERIENCING PAIN AT THE RECONSTRUCTION SITE. THERE WAS NO INFECTION AND THE MANDIBLE WAS RESTORED. PAIN DECREASED AND THE RECONSTRUCTION REMAINED COMPLETE FOR 22 MONTHS AFTER PLACING THE RHBMP-2 TISSUE ENGINEERED GRAFT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSE BONE GRAFT INFUSE BONE GRAFT NEK MEDTRONIC SOFAMOR DANEK USA, INC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 43 YR Required Intervention